EUVIMEDEUVIMED entdecken
Open Access

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy

Hayato Tada, Masayuki Takamura

Journal of Atherosclerosis and Thrombosis · 01.07.2026 · 33 (7) · 882-883

DOI: 10.5551/jat.ed302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.07.2026. Verfasst von Hayato Tada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa University. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa University.

Zitieren

APA

Tada, H., & Takamura, M. (2026). An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy. Journal of Atherosclerosis and Thrombosis, 33(7), 882-883. https://doi.org/10.5551/jat.ed302

Vancouver

Tada H, Takamura M. An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy. Journal of Atherosclerosis and Thrombosis. 2026;33(7):882-883. doi:10.5551/jat.ed302

BibTeX
@article{Tada2026,
  author = {Tada, Hayato and Takamura, Masayuki},
  title = {An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {882--883},
  doi = {10.5551/jat.ed302}
}
Kostenlos starten →